ACETYL CHOLINE RECEPTOR ANTIBODIES (AChRAb) Test in UAE

Acetylcholine Receptor Antibodies (AChRab) Test in Dubai and across the UAE to diagnose autoimmune neuromuscular disorders. This specialized blood test detects antibodies that attack acetylcholine receptors at the neuromuscular junction — a key marker for myasthenia gravis (MG), a condition causing muscle weakness and fatigue. Results available within 5–7 days.

Overview

The Acetylcholine Receptor Antibodies (AChRab) Test identifies the presence of autoantibodies that mistakenly target acetylcholine receptors in the body’s neuromuscular pathways. These antibodies disrupt nerve-to-muscle communication, leading to muscle weakness — especially in the eyes, face, throat, and limbs. This test is the gold standard for confirming myasthenia gravis (MG), a chronic but treatable autoimmune disorder. Results are typically available within 5–7 business days due to specialized laboratory processing.

Why You Need This Test

• Diagnose myasthenia gravis (MG) — a common cause of unexplained muscle weakness.
• Evaluate symptoms like drooping eyelids (ptosis), double vision (diplopia), or difficulty swallowing.
• Investigate progressive limb weakness that worsens with activity and improves with rest.
• Rule out autoimmune causes in patients with chronic fatigue or voice changes.
• Support diagnosis when edrophonium (Tensilon) test or EMG results are inconclusive.
• Monitor disease progression or treatment response in known MG patients.
• Available with home blood collection across Dubai, Abu Dhabi, Sharjah, and all Emirates.

Symptoms & Risk Factors

Common Symptoms

• Drooping eyelids (ptosis) — often the first sign
• Double or blurred vision (diplopia)
• Difficulty speaking, chewing, or swallowing
• Weakness in arms, hands, legs, or neck that worsens with use
• Breathing difficulties in severe cases (myasthenic crisis)
• Fatigue that increases throughout the day

Risk Factors

• Women under 40 and men over 60 — most commonly affected age groups
• Autoimmune history — such as lupus, rheumatoid arthritis, or thyroid disease
• Thymus gland abnormalities — including thymoma or thymic hyperplasia
• Family history of autoimmune or neuromuscular disorders
• Viral infections or immune triggers preceding symptom onset
• Post-COVID or post-vaccination autoimmune reactions (rare)

How the Test Works

In myasthenia gravis, the immune system produces antibodies that block or destroy acetylcholine receptors, preventing muscles from receiving nerve signals. The AChRab test measures three types of antibodies: **binding**, **blocking**, and **modulating** — with binding antibodies being the most commonly detected.

• Step 1 — Appointment: schedule a lab visit or request home blood draw.
• Step 2 — Sample collection: a small blood sample is taken from your arm.
• Step 3 — Laboratory analysis: performed using radioimmunoprecipitation assay (RIPA) or ELISA methods.
• Step 4 — Results: securely delivered within 5–7 business days.

This test is essential for confirming myasthenia gravis and guiding treatment with immunosuppressants, IVIG, or thymectomy.

Sample Type

• We take: Venous blood sample (from the arm)
• Volume: 3–5 mL
• Container: serum separator tube (SST)
• Fasting: not required
• Special handling: serum must be separated promptly and stored at 2–8°C
• Note: hemolyzed or lipemic samples may interfere with accuracy

Risks & Safety

• Minimal risk — slight pain or bruising at the needle site.
• No recovery time needed; resume normal activities immediately.
• Safe for adults and older children.
• Performed by trained phlebotomists using sterile, single-use equipment.
• No side effects from the test itself.

Result Interpretation

Normal Range

• Negative: < 0.05 nmol/L (binding antibodies)
• Results may vary slightly depending on method and lab reference values.

Positive Results

• Typically indicate:
  • Myasthenia gravis (MG) — present in ~85% of generalized cases
  • Ocular myasthenia — lower positivity rate (~50%)
  • Thymoma-associated MG — often high antibody levels

Negative but Symptomatic?

• May suggest:
  • Seronegative myasthenia gravis — test for MuSK or LRP4 antibodies
  • Other neuromuscular disorders — e.g., Lambert-Eaton syndrome, ALS
  • Early-stage disease — retesting may be needed later

Consequences if Untreated

• Progressive muscle weakness affecting mobility, speech, and swallowing.
• Myasthenic crisis — life-threatening respiratory failure requiring ICU care.
• Chronic fatigue and reduced quality of life.
• Increased risk of aspiration pneumonia due to swallowing difficulties.
• Long-term disability without proper diagnosis and treatment.

Factors Affecting Test Results

• Recent immunotherapies: plasmapheresis, IVIG, or high-dose steroids may lower antibody levels.
• Thymectomy: surgery to remove the thymus can reduce antibody production over time.
• Disease duration: early MG may not yet show detectable antibodies.
• Antibody type: MuSK or LRP4 antibodies not detected by standard AChRab test.
• Medications: cholinesterase inhibitors (e.g., pyridostigmine) do not affect antibody levels.
• Lab methodology: sensitivity varies between assays — use of RIPA is considered most accurate.

FAQs

Limitations

• Not all myasthenia gravis patients test positive — seronegative MG requires additional antibody testing (MuSK, LRP4).
• Results take longer (5–7 days) due to specialized lab techniques.
• Does not reflect disease severity — antibody levels don’t always correlate with symptoms.
• False negatives possible in ocular or early-stage MG.
• Not used for routine screening — only for symptomatic patients.

Book Your AChRab Test Today

Don’t ignore unexplained muscle weakness or drooping eyelids — get an accurate diagnosis for myasthenia gravis and start effective treatment.

• Home Blood Collection Available (Dubai, Abu Dhabi, Sharjah, Ajman, RAK, Umm Al Quwain, Fujairah)
• Precise, Lab-Confirmed Results in 5–7 Days
• Price: AED 450
• ✅ Accredited Labs | Neurology-Grade Testing
• 🩸 Expert Phlebotomists | Comfortable Draw
• 🔒 Confidential & Secure Reporting